HealthEquity, Inc. (NASDAQ:HQY) Director Sells $639,917.50 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

HealthEquity Price Performance

NASDAQ:HQY opened at $112.69 on Friday. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $9.77 billion, a PE ratio of 103.39, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. The stock’s 50-day moving average price is $102.14 and its 200-day moving average price is $90.76.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm earned $0.40 EPS. As a group, equities analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently commented on HQY. Royal Bank of Canada increased their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Barrington Research raised their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Bank of America raised their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Finally, The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price for the company. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $110.71.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently modified their holdings of the business. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity during the 4th quarter valued at about $26,000. Transce3nd LLC purchased a new position in HealthEquity in the 4th quarter valued at about $29,000. Smartleaf Asset Management LLC lifted its stake in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares in the last quarter. UMB Bank n.a. lifted its stake in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ lifted its stake in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock valued at $45,000 after buying an additional 445 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.